|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | ||
| Non cash operating lease expense | ||
| Accretion and amortization of marketable securities, net | ||
| Depreciation expense | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Other assets | ||
| Operating lease right-of-use asset | ||
| Operating lease liability | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of property and equipment | ||
| Purchases of marketable securities | ||
| Maturities of marketable securities | ||
| Call redemptions of marketable securities | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from public offering, net of underwriting discounts and commissions | ||
| Proceeds from initial public offering, net of underwriting discounts and commissions | ||
| Proceeds from exercise of common stock options | ||
| Preferred stock issuance costs | ||
| Net cash provided by financing activities | ||
| Net increase in cash and cash equivalents | ||
| Cash and cash equivalents, beginning of period | ||
| Cash and cash equivalents, end of period | ||
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Vesting of early exercised stock options and founder shares | ||
| Property and equipment in accounts payable and accrued liabilities | ||
| Deferred initial public offering costs included in accounts payable and accrued expenses | ||
| Conversion of convertible preferred stock to common stock upon initial public offering |
Loading...
